Cell-Based Potency Assay for Anti-CD3-Anti-CD19 Diabody
Tania L. Weiss, Justine Paniagua, Tonny Johnson, Timothy P. Cripe, P Ralph
The paper develops a GMP-compliant cell-based potency assay to measure the efficacy of GP101, a CD3-CD19 diabody, using fluorescence detection of T-cell mediated B-cell lysis.
Journal of Immunological Methods · Nov 14, 2025Peer-reviewedCancer Biology